Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Pharmacia & Upjohn reveals non-enzymatic protein glycosylation inhibitors

July 19, 1996

Hemosol's hemoglobin manufacturing process covered under U.S. patent

July 19, 1996

KGF in preclinical development in Japan for mucositis

July 19, 1996

ImmuCell and Agri-Mark form joint venture for bovine lactoferrin production and commercialization

July 19, 1996

Cholesterol absorption inhibitors from Schering-Plough

July 19, 1996

Bile acid reabsorption inhibitors described by Glaxo Wellcome

July 19, 1996

Cathepsin L inhibitors described by Takeda

July 19, 1996

Vitamin D compounds with preferencial calcemic and cell differation inducing activity described

July 19, 1996

RWJ-26819: Non-steroidal progestin agonist from R.W. Johnson

July 12, 1996

U.K. and Canadian approval sought for Alora

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...